Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. more
Time Frame | SMTI | Sector | S&P500 |
---|---|---|---|
1-Week Return | -7.18% | -3.39% | 0.2% |
1-Month Return | -3.9% | -1.92% | 2.72% |
3-Month Return | 4.1% | -10.54% | 7.31% |
6-Month Return | 17.13% | -4.47% | 10.44% |
1-Year Return | -9.63% | 4.06% | 27.53% |
3-Year Return | 28.12% | 0.94% | 30.88% |
5-Year Return | 139.37% | 36.67% | 89.21% |
10-Year Return | 466.5% | 102.87% | 199.95% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 11.77M | 15.59M | 24.14M | 45.84M | 64.99M | [{"date":"2019-12-31","value":18.11,"profit":true},{"date":"2020-12-31","value":23.98,"profit":true},{"date":"2021-12-31","value":37.15,"profit":true},{"date":"2022-12-31","value":70.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 1.21M | 1.62M | 2.31M | 6.36M | 7.85M | [{"date":"2019-12-31","value":15.4,"profit":true},{"date":"2020-12-31","value":20.59,"profit":true},{"date":"2021-12-31","value":29.43,"profit":true},{"date":"2022-12-31","value":81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 10.56M | 13.97M | 21.83M | 39.48M | 57.14M | [{"date":"2019-12-31","value":18.48,"profit":true},{"date":"2020-12-31","value":24.45,"profit":true},{"date":"2021-12-31","value":38.21,"profit":true},{"date":"2022-12-31","value":69.1,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 89.72% | 89.63% | 90.43% | 86.12% | 87.92% | [{"date":"2019-12-31","value":99.22,"profit":true},{"date":"2020-12-31","value":99.12,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.24,"profit":true},{"date":"2023-12-31","value":97.22,"profit":true}] |
Operating Expenses | 13.19M | 18.97M | 29.21M | 51.71M | 61.13M | [{"date":"2019-12-31","value":21.57,"profit":true},{"date":"2020-12-31","value":31.04,"profit":true},{"date":"2021-12-31","value":47.78,"profit":true},{"date":"2022-12-31","value":84.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (2.63M) | (5.00M) | (7.38M) | (12.23M) | (4.22M) | [{"date":"2019-12-31","value":-263005700,"profit":false},{"date":"2020-12-31","value":-500461300,"profit":false},{"date":"2021-12-31","value":-737615700,"profit":false},{"date":"2022-12-31","value":-1223243400,"profit":false},{"date":"2023-12-31","value":-421515300,"profit":false}] |
Total Non-Operating Income/Expense | (311.64K) | 577.94K | (618.35K) | (1.70M) | (697.79K) | [{"date":"2019-12-31","value":-53.92,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-106.99,"profit":false},{"date":"2022-12-31","value":-294.96,"profit":false},{"date":"2023-12-31","value":-120.74,"profit":false}] |
Pre-Tax Income | (2.84M) | (4.45M) | (7.99M) | (13.94M) | (4.44M) | [{"date":"2019-12-31","value":-283577800,"profit":false},{"date":"2020-12-31","value":-444514500,"profit":false},{"date":"2021-12-31","value":-799379500,"profit":false},{"date":"2022-12-31","value":-1393712400,"profit":false},{"date":"2023-12-31","value":-443990200,"profit":false}] |
Income Taxes | 94.43K | (62.35K) | (688.10K) | (5.84M) | (136.71K) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-66.04,"profit":false},{"date":"2021-12-31","value":-728.71,"profit":false},{"date":"2022-12-31","value":-6189.75,"profit":false},{"date":"2023-12-31","value":-144.77,"profit":false}] |
Income After Taxes | (2.93M) | (4.38M) | (7.31M) | (8.09M) | (4.30M) | [{"date":"2019-12-31","value":-293020500,"profit":false},{"date":"2020-12-31","value":-438279000,"profit":false},{"date":"2021-12-31","value":-730569800,"profit":false},{"date":"2022-12-31","value":-809232800,"profit":false},{"date":"2023-12-31","value":-430319700,"profit":false}] |
Income From Continuous Operations | (2.84M) | (4.45M) | (7.99M) | (8.09M) | (8.34M) | [{"date":"2019-12-31","value":-283577800,"profit":false},{"date":"2020-12-31","value":-444514500,"profit":false},{"date":"2021-12-31","value":-799379500,"profit":false},{"date":"2022-12-31","value":-809232800,"profit":false},{"date":"2023-12-31","value":-834094300,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (2.93M) | (4.38M) | (7.31M) | (8.09M) | (4.30M) | [{"date":"2019-12-31","value":-293020500,"profit":false},{"date":"2020-12-31","value":-438279000,"profit":false},{"date":"2021-12-31","value":-730569800,"profit":false},{"date":"2022-12-31","value":-809232800,"profit":false},{"date":"2023-12-31","value":-430319700,"profit":false}] |
EPS (Diluted) | (1.33) | (0.79) | (1.08) | (1.39) | (0.52) | [{"date":"2019-12-31","value":-133,"profit":false},{"date":"2020-12-31","value":-79,"profit":false},{"date":"2021-12-31","value":-108,"profit":false},{"date":"2022-12-31","value":-139,"profit":false},{"date":"2023-12-31","value":-52,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
SMTI | |
---|---|
Cash Ratio | 1.14 |
Current Ratio | 2.23 |
Quick Ratio | 2.02 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SMTI | |
---|---|
ROA (LTM) | -5.08% |
ROE (LTM) | -20.28% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
SMTI | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.55 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.45 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SMTI | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 3.81 |
P/B | 7.47 |
Price/FCF | 146 |
EV/R | 4.01 |
EV/Ebitda | NM |
Sanara Medtech Inc (SMTI) share price today is $33.093
Yes, Indians can buy shares of Sanara Medtech Inc (SMTI) on Vested. To buy Sanara Medtech Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SMTI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Sanara Medtech Inc (SMTI) via the Vested app. You can start investing in Sanara Medtech Inc (SMTI) with a minimum investment of $1.
You can invest in shares of Sanara Medtech Inc (SMTI) via Vested in three simple steps:
The 52-week high price of Sanara Medtech Inc (SMTI) is $43.25. The 52-week low price of Sanara Medtech Inc (SMTI) is $26.
The price-to-earnings (P/E) ratio of Sanara Medtech Inc (SMTI) is
The price-to-book (P/B) ratio of Sanara Medtech Inc (SMTI) is 7.47
The dividend yield of Sanara Medtech Inc (SMTI) is 0.00%
The market capitalization of Sanara Medtech Inc (SMTI) is $297.11M
The stock symbol (or ticker) of Sanara Medtech Inc is SMTI